Global Information
회사소개 | 문의 | 비교리스트

세계의 사코페니아(근육감소증) 치료 시장 : 종류별, 용도별, 지역별 예측

Global Sarcopenia Treatment Market Size study, by Type (Presarcopenia, Sarcopenia, Severe Sarcopenia), Application (Hospitals, Clinics, Ambulatory Surgical Centers) and Regional Forecasts 2018-2025

리서치사 Bizwit Research & Consulting LLP
발행일 2019년 05월 상품 코드 843155
페이지 정보 영문
가격
US $ 4,950 ₩ 5,974,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,543,000 Printable PDF (Enterprise License)


세계의 사코페니아(근육감소증) 치료 시장 : 종류별, 용도별, 지역별 예측 Global Sarcopenia Treatment Market Size study, by Type (Presarcopenia, Sarcopenia, Severe Sarcopenia), Application (Hospitals, Clinics, Ambulatory Surgical Centers) and Regional Forecasts 2018-2025
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 사코페니아 치료(Sarcopenia Treatment) 시장을 조사했으며, 시장 개요, 종류·용도·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 주요 요약

  • 시장 현황
  • 주요 동향
  • 세계 및 부문별 시장 예측
    • 종류별
    • 용도별
    • 지역별
  • 예측 방법
  • 조사의 전제조건

제2장 시장 정의와 범위

  • 조사 목적
  • 시장 정의와 범위
    • 산업 발전
    • 조사 범위
  • 조사기간
  • 통화 환산율

제3장 시장 역학

  • See Saw 분석
    • 시장 성장 촉진요인
    • 시장의 과제
    • 시장 기회

제4장 시장 업계 분석

  • Five Forces 분석
    • 구매자의 협상력
    • 공급업체의 협상력
    • 신규 참여업체의 위협
    • 대용품의 위협
    • 경쟁 구도
    • Five Forces 모델에 대한 미래지향적 접근
  • PEST 분석
    • 정치 시나리오
    • 경제 시나리오
    • 사회적 시나리오
    • 기술 시나리오
  • 주요 구매 기준
  • 규제 프레임워크
  • 투자/도입 시나리오
  • 애널리스트의 제안과 결론

제5장 사코페니아 치료 시장 : 종류별

  • 시장 현황
  • 시장 성과 : 잠재적 모델
  • 하위 부문 분석
    • 근량 감소
    • 사코페니아
    • 중증 사코페니아

제6장 사코페니아 치료 시장 : 용도별

  • 시장 현황
  • 시장 성과 : 잠재적 모델
  • 하위 부문 분석
    • 병원
    • 진료소
    • 외래수술센터

제7장 사코페니아 치료 시장 : 지역별

  • 지역 시장 현황
  • 북미 시장 현황
    • 미국
    • 캐나다
  • 유럽 시장 현황
    • 영국
    • 독일
    • 기타
  • 아시아 시장 현황
    • 중국
    • 인도
    • 일본
    • 기타
  • 중남미 시장 현황
    • 브라질
    • 멕시코
  • 기타
    • 남미
    • 중동 및 아프리카

제8장 경쟁사 정보

  • 기업의 시장 점유율(데이터 입수 가능성별)
  • 주요 시장 전략
  • 기업 개요
    • Radius Health
    • GTX
    • Five Prime Therapeutics
    • EZ Facility
    • Club Manager
    • Sports Engine
    • Team Sideline
    • Team Tracky

제9장 조사 방법

  • 조사 방법
    • 데이터 마이닝
    • 분석
    • 시장 예측
    • 검증
    • 출판
    • 조사의 전제조건
LSH 19.06.07

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF SARCOPENIA TREATMENT MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF SARCOPENIA TREATMENT MARKET
  • TABLE 3. SARCOPENIA TREATMENT MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
  • TABLE 8. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
  • TABLE 9. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. SARCOPENIA TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. SARCOPENIA TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW SARCOPENIA TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. SARCOPENIA TREATMENT MARKET, RESEARCH METHODOLOGY
  • FIG 2. SARCOPENIA TREATMENT MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. SARCOPENIA TREATMENT MARKET, KEY TRENDS 2016
  • FIG 5. SARCOPENIA TREATMENT MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. SARCOPENIA TREATMENT MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. SARCOPENIA TREATMENT MARKET, PEST ANALYSIS
  • FIG 8. SARCOPENIA TREATMENT MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. SARCOPENIA TREATMENT MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. SARCOPENIA TREATMENT MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA SARCOPENIA TREATMENT MARKET 2015 & 2025 (USD BILLION)
  • FIG 33. EUROPE SARCOPENIA TREATMENT MARKET 2015 & 2025 (USD BILLION)
  • FIG 34. ASIA PACIFIC SARCOPENIA TREATMENT MARKET 2015 & 2025 (USD BILLION)
  • FIG 35. LATIN AMERICA SARCOPENIA TREATMENT MARKET 2015 & 2025 (USD BILLION)
  • FIG 36. SARCOPENIA TREATMENT MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

Global sarcopenia treatment market is valued approximately USD 2208.4 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period 2018-2025. Reduction of muscle mass considering Sarcopenia leads to loss in muscle function aligned with high changes of functional impairment, mortality and disability in the adult population. Furthermore, malnutrition is one of the emerging causes for early age sarcopenia specially in developing regions. Also changing lifestyle and physical inactivity has led to early age sarcopenia. Increasing prevalence and lack of permanent cure has led to several research and development across the disease. Further changing lifestyles has increased the impact of the disease among the adults in their early 30s. Several initiatives have been taken against the diseases. One such initiative is Canada Sarcopenia Foundation, which is dedicated to preventing and reverse the course of metabolic disease and sarcopenia.

Increasing prevalence of sarcopenia across the adults at early age and the rising awareness levels of the consumers is anticipated to drive the growth in pre-sarcopenia market over the forecast period. On the basis of type the Global Sarcopenia market is segmented into Pre-Sarcopenia, Sarcopenia, Severe Sarcopenia. Currently, the market is dominated by sarcopenia market with a majority revenue share of 43.55% in 2017. Sarcopenia is getting very prevalent across the age group of 50-80 years. Severe sarcopenia is more prevalent across people of age group above 80 years. Severe sarcopenia affects both physical performance and strength which includes loss of muscle mass.

Knowledge about sarcopenia has increased during the past decade. Various epidemiological and pathophysiological aspects are better understood today than few years ago. Researchers have found that muscle pathology can cause adverse health effect and it is evident with various studies that this adverse consequence are treatable, and the effects can be delayed through certain treatment strategies. The advancement of sarcopenia treatment such as Ursolic acid is a pentaciclyc triterpenoid found in apples. This acid has the potential to reduce muscle weakness and atrophy associated aging. Ursolic acid stimulate an increase in muscle by repressing atrophy-associated skeletal muscle gene expression. These is the major factor that spur the growth of investment for drug and supplement development in Sarcopenia treatment market. The rapid increasing investment for drug and supplement development changes the nature of pricing and competition in the market are also become a reason to enhance the market growth over the coming years.

The regional analysis of global sarcopenia treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to surging prevalence of cancer and chronic diseases. Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2018-2025 due to escalating prevalence of geriatric population and surging incidences of diabetes.

Market player included in this report are:

  • Abbott Laboratories
  • Pfizer Inc
  • Novartis AG
  • Glaxosmithkline Plc
  • Nestle SA
  • Bayer AG
  • Sanofi SA
  • Amway

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Presarcopenia
  • Sarcopenia
  • Severe Sarcopenia

By Application:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2015, 2016
  • Base year - 2017
  • Forecast period - 2018 to 2025

Target Audience of the Global Sarcopenia Treatment Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. Sarcopenia Treatment Market, by Type, 2015-2025 (USD Billion)
    • 1.3.2. Sarcopenia Treatment Market, by Application, 2015-2025 (USD Billion)
    • 1.3.3. Sarcopenia Treatment Market, by Region, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Sarcopenia Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Sarcopenia Treatment Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Sarcopenia Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria
  • 4.4. Regulatory Framework
  • 4.5. Investment Vs Adoption Scenario
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Sarcopenia Treatment Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Sarcopenia Treatment Market, Sub Segment Analysis
    • 5.3.1. Presarcopenia
      • 5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.2. Sarcopenia
      • 5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.3. Severe Sarcopenia
      • 5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Sarcopenia Treatment Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Sarcopenia Treatment Market, Sub Segment Analysis
    • 6.3.1. Hospitals
      • 6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.2. Clinics
      • 6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.3. Ambulatory Surgical Centers
      • 6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Sarcopenia Treatment Market, by Regional Analysis

  • 7.1. Sarcopenia Treatment Market, Regional Market Snapshot (2015-2025)
  • 7.2. North America Sarcopenia Treatment Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion
  • 7.3. Europe Sarcopenia Treatment Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. Rest of Europe
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.4. Asia Sarcopenia Treatment Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.5. Latin America Sarcopenia Treatment Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Radius Health
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. GTX
    • 8.3.3. Five Prime Therapeutics
    • 8.3.4. EZ Facility
    • 8.3.5. Club Manager
    • 8.3.6. Sports Engine
    • 8.3.7. Team Sideline
    • 8.3.8. Team Tracky

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption
Back to Top
전화 문의
F A Q